Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma

被引：4
|
作者：
Giaccone, L. [1 ,2 ]
Festuccia, M. [3 ]
Zallio, F. [4 ]
Sorasio, R. [5 ]
Brunello, L. [2 ,3 ]
Maffini, E. [1 ,2 ]
Dellacasa, C. [1 ]
Passera, R. [6 ]
Iovino, G. [7 ]
Aydin, S. [7 ]
Boccadoro, M. [2 ,3 ]
Vitolo, U. [7 ]
Mordini, N. [5 ]
Pini, M. [4 ]
Busca, A. [1 ]
Bruno, B. [1 ,2 ]
机构：
[1] AOU Citta Salute & Sci Torino, Dipartimento Oncol, SSD Trapianto Allogen Cellule Staminali, Turin, Italy
[2] Univ Torino, Scuola Med, Dipartimento Biotecnol Mol & Sci Salute, Turin, Italy
[3] AOU Citta Salute & Sci Torino, Dipartimento Oncol, Ematol U, Turin, Italy
[4] AO Antonio & Biagio & C Arrigo, SS Trapianti SC Ematol, Alessandria, Italy
[5] AO Santa Croce & Carle, UO Ematol, Cuneo, Italy
[6] AOU Citta Salute & Sci Torino, Div Med Nucl 2, Turin, Italy
[7] AOU Citta Salute & Sci Torino, Dipartimento Oncol, Ematol, Turin, Italy
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 08期
关键词：
BRENTUXIMAB VEDOTIN; REDUCED-INTENSITY; MARROW-TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; EUROPEAN GROUP; WORKING PARTY; EXPERIENCE; BLOOD; REGIMEN;
D O I：
10.1038/bmt.2017.99
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1208 / 1211
页数：4
相关论文
共 50 条
  • [21] Long-term follow-up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma
    Puckrin, Robert
    Chua, Neil
    Chin, Kelly
    Peters, Anthea
    Duggan, Peter
    Shafey, Mona
    Storek, Jan
    Jamani, Kareem
    Owen, Carolyn
    Stewart, Douglas
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (02) : 319 - 325
  • [22] Allogeneic stem cell transplantation in patients with refractory acute leukaemia;: a long-term follow-up of 44 patients
    Oyekunle, AA
    Zabelina, T
    Schieder, H
    Ayuk, F
    Renges, H
    Fehse, N
    Fehse, B
    Kabisch, H
    Zander, AR
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2005, 35 : S219 - S219
  • [23] Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma
    Wang, Michael
    Rule, Simon
    Zinzani, Pier Luigi
    Goy, Andre
    Casasnovas, Olivier
    Smith, Stephen D.
    Damaj, Gandhi
    Doorduijn, Jeanette K.
    Lamy, Thierry
    Morschhauser, Franck
    Panizo, Carlos
    Shah, Bijal D.
    Davies, Andrew
    Eek, Richard
    Dupuis, Jehan
    Jacobsen, Eric
    Kater, Arnon P.
    Gouill, Steven L. E.
    Oberic, Lucie
    Robak, Tadeusz
    Dua, Richa
    Frigault, Melanie M.
    Izumi, Raquel
    Nguyen, Dorothy
    Patel, Priti
    Yin, Ming
    Jurczak, Wojciech
    BLOOD, 2018, 132
  • [24] Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma
    Wang, Michael
    Rule, Simon
    Zinzani, Pier Luigi
    Goy, Andre
    Casasnovas, Oliver
    Smith, Stephen
    Damaj, Gandhi
    Doorduijn, Jeanette K.
    Lamy, Thierry
    Morschhauser, Franck
    Panizo, Carlos
    Shah, Bijal
    Davies, Andrew
    Eek, Richard
    Dupuis, Jehan
    Jacobsen, Eric
    Kater, Arnon P.
    Le Gouill, Steven
    Oberic, Lucie
    Robak, Tadeusz
    Dua, Richa
    Frigault, Melanie M.
    Izumi, Raquel
    Nguyen, Dorothy
    Patel, Priti
    Yin, Ming
    Jurczak, Wojciech
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S316 - S316
  • [25] Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer
    Omazic, Brigitta
    Remberger, Mats
    Barkholt, Lisbeth
    Soderdahl, Gunnar
    Potacova, Zuzana
    Wersall, Peter
    Ericzon, Bo-Goran
    Mattsson, Jonas
    Ringden, Olle
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (04) : 676 - 681
  • [26] Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer
    Ringden, Olle
    Remberger, Mats
    Barkholt, Lisbeth
    Soderdahl, Gunnar
    Potacova, Zuzana
    Wersall, Peter
    Ericzon, Bo-Goran
    Mattsson, Jonas
    Omazic, Brigitta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S423 - S424
  • [27] Long term follow-up after autologous stem cell transplantation for chemoresistent Hodgkin's lymphoma
    Pavone, V
    Gaudio, F
    Guarini, A
    Perrone, T
    Curci, P
    Giordano, A
    De Francesco, R
    Liso, V
    ANNALS OF ONCOLOGY, 2005, 16 : 198 - 198
  • [28] Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey
    Uysal, Ayse
    Soyer, Nur Akad
    Ozdogu, Hakan
    Goker, Hakan
    Cinar, Olgu Erkin
    Deveci, Burak
    Yilmaz, Asu Fergun
    Atagunduz, Isik Kaygusuz
    Tekgunduz, Ali Irfan Emre
    Izmir, Sebnem Guner
    Vural, Filiz
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 43 - 52
  • [29] Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Castagna, Luca
    Carlo-Stella, Carmelo
    Mazza, Rita
    Santoro, Armando
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
  • [30] Allogeneic stem cell transplantation for relapsed or refractory Hodgkin lymphoma: a better therapeutical perspective
    Greco, M. M.
    Carella, A. M.
    Merla, E.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S288 - S289
12345